Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions - 04/02/21
Doi : 10.1016/j.jaci.2020.05.056
Janina Petry, PhD a, ∗, Johann Rahmöller, MD a, b, ∗, Lara Dühring, MSc a, ∗, Gina-Maria Lilienthal, PhD a, Selina Lehrian, MSc a, Jana Sophia Buhre, MSc a, Yannic C. Bartsch, PhD a, Alexandra Epp, PhD a, Hanna B. Lunding, MSc a, Kelley W. Moremen, PhD c, Alexei Leliavski, PhD a, Marc Ehlers, PhD a, d 
a Laboratories of Immunology and Antibody Glycan Analysis, Institute for Nutritional Medicine, University of Lübeck and University Medical Center Schleswig-Holstein, Lübeck, Germany
b Department of Anesthesiology and Intensive Care, University of Lübeck and University Medical Center of Schleswig-Holstein, Lübeck, Germany
c Complex Carbohydrate Research Center, University of Georgia, Athens, Ga
d Airway Research Center North, University of Lübeck, German Center for Lung Research (DZL), Lübeck, Germany
| M.E. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international Research Training Group - iRTG 1911), 49701054 (Germany’s Excellence Strategies - EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])—and the VolkswagenStiftung (grant no. 97301). A.L. received junior grants from the University of Lübeck and the EXC 306. Y.C.B. and H.B.L. were members and J.P., L.D., S.L., and G.-M.L. were associated members of the RTG 1727. A.E. and J.R. were members of the iRTG 1911. |
|
| Disclosure of potential conflict of interest: M. Ehlers received grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—grant numbers 257739680 (EH 221/8-1), 398859914 (EH 221/10-1), 222374435 (international iRTG 1911), 49701054 (Germany’s Excellence Strategies - EXC 306) and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI])—and the Volkswagenstiftung (grant no. 97301) for this work and grants from the DFG—grant numbers 400912066 (EH 221/11-1), 269234613 (Clinical Research Unit 303, EH 221/9-1), 179309734 (RTG 1727)—and the Else Kroener-Fresenius-Foundation (2014_A91) for other works; and is employed by the University of Lübeck. A. Leliavski received junior grants from the University of Lübeck, and the EXC 306 for other works. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 2
P. 763-767 - Febbraio 2021 Ritorno al numero
Articolo precedente
- Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22–producing skin T-cell overactivation
- Chao Li, Ming Xu, James Coyne, Wei-Bei Wang, Micha L. Davila, Yong Wang, Na Xiong
- CD4+CD25highCD226low/– cells: An innovative approach to identify human regulatory T cells
- Yu Liu, Guangying Qi, Julie Wang, Feng Huang, Joseph A. Bellanti, Song Guo Zheng
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?